ADVERTISING POLICY · 1 OCTOBER 2026
Advertising and sponsorship policy
Solace may publish carefully reviewed commercial messages that are relevant to readers interested in responsible endurance practice. Advertising is not editorial coverage, and payment cannot determine an article’s conclusion, ranking, review, or correction. This policy applies to display placements, sponsorships, affiliate links, events, and any future commercial format presented on the 2026 site.
1. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
2. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
3. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
4. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
5. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
6. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
7. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
8. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
9. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
10. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
11. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
12. Clear separation and review
Commercial material must be distinguishable through labels such as “Advertisement,” “Sponsored,” or “Partner message” and must not imitate an independent Solace article. The desk reviews the identity, relevance, and basic claims of a prospective advertiser, but that review is not a clinical endorsement or guarantee of safety. Solace rejects claims that promise a guaranteed result, exploit fear, misrepresent research, target a medical vulnerability, or encourage unsafe use of products. Affiliate relationships are disclosed near the relevant link, and links may include tracking technologies described in the Cookie Policy. Readers should evaluate products independently and consult qualified professionals for health decisions. Conflicts are recorded, access to campaign materials is limited, and editorial staff may decline or remove a placement if facts change. Complaints can be sent through contact.php or to +62 21 726 1835, with the page, label, advertiser, and concern included. Solace aims to respond within 30 days. This policy was reviewed on 1 October 2026; material updates receive a new date and explanation.
13. Advertiser contact
Commercial enquiries may be sent to the Jakarta address shown across the site. A commercial enquiry does not create a promise of publication, audience size, editorial treatment, or acceptance.
Before publication, commercial material is checked for clear ownership, a stated purpose, understandable pricing or participation terms where relevant, and language that does not imply medical, financial, or performance outcomes without adequate support. A label remains visible on the page, in a newsletter placement, and beside an affiliate link rather than being hidden in a footer. Advertiser materials are not allowed to alter source selection, headlines, corrections, or the wording of independent editorial work.
Campaign records may include the contact person, business name, placement dates, approval notes, and invoices. Commercial correspondence is generally retained for 24 months after the last active discussion, while campaign reporting may be retained for up to 13 months when it contains aggregated performance information. Personal information is handled under the Privacy Policy, and readers may ask about tracking choices through the Cookie Policy.
Concerns about a label, claim, link, or sponsorship can be sent to Jalan Cempaka Putih Raya No. 15, RT.8/RW.5, Cempaka Putih Barat, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta 10520, Indonesia, or +62 21 726 1835. Please include the page, date, visible label, and specific concern. Solace aims to acknowledge a complaint within 7 days and provide an initial review within 30 days. The policy was reviewed on 1 October 2026 and material changes will be dated.
Commercial material is reviewed for clear ownership, visible labelling, understandable terms, and claims that can be supported by the information supplied. A label remains near the placement, newsletter item, affiliate link, or sponsored feature rather than being hidden in a general footer. Advertisers cannot control independent source selection, editorial conclusions, corrections, or the presentation of unrelated coverage. Solace may decline material that creates confusion about the publication’s role.
Commercial records may include the business name, contact person, placement dates, approval notes, invoices, and the final creative. Those records are normally retained for 24 months after the last active discussion, while aggregated campaign reporting may remain for up to 13 months. Personal information is handled under the Privacy Policy, and tracking choices are described in the Cookie Policy. International providers may process limited campaign information under contractual and access safeguards.
Concerns about a label, claim, link, or sponsorship may be sent to Jalan Cempaka Putih Raya No. 15, RT.8/RW.5, Cempaka Putih Barat, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta 10520, Indonesia, or +62 21 726 1835. Please include the page, visible label, advertiser, date, and concern; do not send confidential records. Solace aims to acknowledge complaints within 7 days and provide an initial review within 30 days. This policy was reviewed on 1 October 2026.